Skip to main content

Table 4 Strengths and Limitations of the Selected Study Articles

From: Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review

Name of the app

Strengths

Limitations

MedWatcher

Two-way communication channel

Direct patient involvement

User-friendly web and mobile app

Increase efficiency

Utilization of the VigiGrade completeness scores to evaluate the quality of the data

Anonymized versions were available for privacy and safety

Images can be submitted

More complete reports

The app is primarily intended for the patients using the app reside in the USA

Available only in English

VigiBIP

Ease of patient reporting (Data and Photographs of ADRs)

Better clinical characteristics documentation of ADRs for causality assessment

Two-way communication channel

Non-presentiveness of users

Potential lack of medical information

ADR reporting app© (App©)

Ensures mandatory data has been entered leading to valid and complete reports

The reporter information is saved, reducing the need to repetitive data entry

Bilateral standardization has been introduced for the communication gap between input operator and output analyzer

Built-in algorithm for Causality assessment enhances the reporter’s knowledge, objectivity

User friendly interface

Signatures cannot be placed in App© submissions

Only available in Android platforms lacking versions for iOS, Lumia and desktop

Follow up on previous cases need to filled afresh

My eReport France

New opportunities for Real-world Data Collection

Early detection of ADRs

Pictures can be uploaded

Directly report submission to the Regional Center of Pharmacovigilance,

Due to the international diversity of pharmacology systems results may not be directly replicable in other countries with similar ADR reporting mechanisms

Persons with multiple sclerosis, chronic condition with an evolving therapeutic regimen were only included

User experience and app design were not considered

WEB-RADR apps

Contains 3 Apps

(Yellow Card, LAREB, HALMED)

Dual Quality Measurements, vigiGrade (technical completeness of the reports) and ClinDoc (clinical quality)

Potential biases in app user preferences

Med Safety

Designed to support low- and middle-income countries (LMICs) use

Use of this app in low-resource settings

Two-way risk communication

Designed for multi-region use Language

Security of the app

Source of safety information provided through the app

There is currently no study that documents challenges and facilitators for the use of a mobile app for reporting ADRs in LMICs

Concerned about the privacy and security of personal information